Results 301 to 310 of about 116,778 (380)

Detrusor Overactivity and Urodynamics

Neurourology and Urodynamics, EarlyView.
ABSTRACT While overactive bladder (OAB) is a clinical diagnosis, detrusor overactivity is identified through urodynamic testing. UDS is usually considered when primary treatment for OAB fails, because UDS is expensive, time consuming, invasive, and sometimes inaccurate, and it is not considered to influence treatment strategy substantially.
Laura N. Nguyen, Geneviève Nadeau
wiley   +1 more source

First Report on the use of Loop-X Image Acquisition Technology for Sacral Neuromodulation. [PDF]

Int Braz J Urol
Averbeck MA, Hinnah C, de Freitas FF, da Silva ACM, Kowalski A.   +4 more
europepmc   +1 more source

The Evidence for Implantable Sacral Neuromodulation in Pediatric Voiding Dysfunction

Mariam Malallah, Anne P. Cameron, Bryan S. Sack   +2 more
openalex   +1 more source

The effects of musical tempo and non-invasive neuromodulation on autonomic control of the heart [PDF]

, 2017
Beatrice Bretherton
openalex  

Efficacy and Safety of Sacral Neuromodulation on Patients With Multiple Sclerosis and Lower Urinary Tract Dysfunction: A Systematic Review and Meta‐Analysis

Neurourology and Urodynamics, EarlyView.
ABSTRACT Aim Treating multiple sclerosis (MS)‐related adult neurogenic lower urinary tract dysfunction (ANLUTD) is challenging because conservative treatments are often ineffective. Sacral neuromodulation (SNM) is a promising minimally invasive treatment of ANLUTD. This review assesses the efficacy and safety of SNM for MS‐related ANLUTD.
Carlos Ferreira, Paula Soeiro, Sara Fonseca, Zaruhi Arakelyan, João Silva, Carlos Martins Silva, Francisco Cruz, Joana Guimarães, Tiago Antunes Lopes   +8 more
wiley   +1 more source

Long-term explantation risk in patients with chronic pain treated with spinal cord or dorsal root ganglion stimulation. [PDF]

Reg Anesth Pain Med
Gatzinsky K, Brink B, Eyglóardóttir KL, Hallén T.   +3 more
europepmc   +1 more source

Should We Consider Sacral Nerve Stimulation as a Treatment for Neurogenic Lower Urinary Tract Dysfunction? ICI‐RS 2025

Neurourology and Urodynamics, EarlyView.
ABSTRACT Aims To explore the boundary of clinical use of sacral nerve stimulation (SNS) in neurogenic lower urinary tract dysfunction (NLUTD), identifying barriers to approval and early‐impact research questions. Methods This review is derived from a proposal discussion at the International Consultation on Incontinence‐Research Society in Bristol in ...
Marcus J. Drake, Mathijs de Rijk, Stefania Musco, Jalesh Panicker, Michał Późniak, Nikita Bhatt, Brigitte Schurch   +6 more
wiley   +1 more source

Hotspots and trends in acupuncture combined with non-invasive neuromodulation technology in the past 20 years: a bibliometric analysis. [PDF]

Front Neurol
Li S, Dai A, Zhou Y, Chen X, Chen Y, Zhou L, Yang X, Yue M, Shi J, Qiu Y.   +9 more
europepmc   +1 more source

Which Patients With Dysfunctional Voiding Respond Well to Sacral Neuromodulation? ICI‐RS 2025

Neurourology and Urodynamics, EarlyView.
ABSTRACT Aims Dysfunctional voiding (DV) is characterised by fluctuating or intermittent urinary flow during voiding in neurologically normal individuals. Given the different definitions used and heterogeneous pathophysiologies, outcomes following sacral neuromodulation/sacral nerve stimulation (SNM/SNS) are variably reported.
Jalesh N. Panicker, Chris Harding, Hashim Hashim, Claire Hentzen, Nikita Bhatt, Arjun Nambiar, Brigitte Schurch, Mathijs de Rijk, Stefania Musco   +8 more
wiley   +1 more source

Artificial Intelligence-Driven Neuromodulation in Neurodegenerative Disease: Precision in Chaos, Learning in Loss. [PDF]

Biomedicines
Calderone A, Latella D, La Fauci E, Puleo R, Sergi A, De Francesco M, Mauro M, Foti A, Salemi L, Calabrò RS.   +9 more
europepmc   +1 more source